Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy 2022-06-20 12:00
2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines 2022-06-19 10:30
2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines 2022-06-19 10:30
US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER 2022-06-17 20:00
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis 2022-06-17 04:20
Insilico Medicine appoints Dr. Feng Ren as co-CEO 2022-06-16 21:03
Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened 2022-06-16 20:30
Global Pharmaceutical Market Drives Innovative Digitalization to Accelerate Drug Discovery 2022-06-16 15:12
Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology 2022-06-16 13:01
GILEAD SCIENCES NEW DATA HIGHLIGHTS PEOPLE LIVING WITH HIV WHO ARE VIRALLY SUPPRESSED EXPERIENCE SIMILAR HEALTH-RELATED QUALITY OF LIFE AS GENERAL POPULATION 2022-06-16 11:15
WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies 2022-06-16 08:00
Novotech and Medidata expand partnership to continue advancements in clinical research 2022-06-16 08:00
SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting 2022-06-16 00:15
I-Mab Partner MorphoSys Announces New License Agreements for Felzartamab and TJ210 2022-06-15 22:37
AnchorDx's Non-invasive Lung Cancer Early Diagnosis Product, PulmoSeek, Completes EU CE Marking Requirements 2022-06-15 21:00
Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting 2022-06-15 20:01
Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development 2022-06-15 20:00
Pierre Fabre and Lonza Enter Manufacturing Agreement for W0180 Antibody Drug Product 2022-06-15 14:30
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences 2022-06-14 20:00
Zhimeng Biopharma will report positive phase 1b trial results on its HBV capsid inhibitor ZM-H1505R in the upcoming International Liver Congress 2022-06-14 20:00
1 169 170 171 172 173 452